Squarepoint Ops LLC Xenon Pharmaceuticals Inc. Transaction History

Squarepoint Ops LLC

  • $62.8 Billion
  • Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 7,504 shares of XENE stock, worth $291,905. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,504
Holding current value
$291,905
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$36.12 - $43.96 $271,044 - $329,875
7,504 New
7,504 $295,000
Q4 2023

Feb 14, 2024
BUY
$28.7 - $46.46 $236,861 - $383,434
8,253 New
8,253 $380,000
Q3 2022

Nov 14, 2022
BUY
$30.79 - $39.82 $109,458 - $141,560
3,555 Added 50.43%
10,605 $383,000
Q2 2022

Aug 15, 2022
BUY
$25.44 - $35.16 $179,352 - $247,877
7,050 New
7,050 $214,000
Q1 2022

May 16, 2022
SELL
$25.09 - $33.13 $276,341 - $364,893
-11,014 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$15.6 - $35.4 $171,818 - $389,895
11,014 New
11,014 $344,000
Q3 2020

Nov 16, 2020
SELL
$10.82 - $13.35 $263,153 - $324,685
-24,321 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$10.21 - $14.9 $43,709 - $63,786
4,281 Added 21.36%
24,321 $305,000
Q1 2020

May 15, 2020
SELL
$8.08 - $17.57 $97,258 - $211,490
-12,037 Reduced 37.53%
20,040 $227,000
Q4 2019

Feb 14, 2020
SELL
$8.11 - $14.65 $446,236 - $806,086
-55,023 Reduced 63.17%
32,077 $421,000
Q3 2019

Nov 14, 2019
SELL
$8.74 - $10.51 $51,478 - $61,903
-5,890 Reduced 6.33%
87,100 $785,000
Q2 2019

Aug 14, 2019
BUY
$8.51 - $10.75 $517,944 - $654,277
60,863 Added 189.45%
92,990 $917,000
Q1 2019

May 15, 2019
BUY
$6.39 - $10.42 $205,291 - $334,763
32,127 New
32,127 $326,000

Others Institutions Holding XENE

# of Institutions
212
Shares Held
70.2M
Call Options Held
88.3K
Put Options Held
28.8K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.42B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email